Signs of Electrophysiological Myocardial Remodeling in Respiratory Tuberculosis Patients according to Daily ECG Monitoring Data
https://doi.org/10.58838/2075-1230-2025-103-1-14-22
Abstract
The objective: to optimize diagnostics of cardiovascular disorders in respiratory tuberculosis patients during anti-tuberculosis therapy.
Subjects and Methods. A total of 93 patients with pulmonary tuberculosis without concomitant cardiovascular diseases (CVD) were examined. Daily electrocardiogram monitoring was performed for at least 24 hours using 3 leads. The parameters of the myocardial repolarization were analyzed. The results of the study were processed using MS EXCEL 2016 for Windows and STATISTICA 10 by nonparametric methods.
Results. Various signs of electrophysiological remodeling (ER) combining with each other were identified. Most often, these changes were expressed in hyperadaptation of QT to heart rate and decrease in dQT and Tp-e values. Increased QTcFmin, dQT, Tp-e were rare. Elevated values of the iCEB index were more often detected in patients with a higher average daily QT duration. No statistically significant differences in ER indices were found between the groups of patients with limited and widespread tuberculosis. Patients with respiratory tuberculosis should have their QT dynamics analyzed and signs of ER should not be limited to QT interval testing alone. QT changes do not depend on the degree of pulmonary tuberculosis dissemination.
About the Authors
A. I. NagaevRussian Federation
Andrey I. Nagaev - Cardiologist of Center for Respiratory Diseases Diagnosis and Rehabilitation
2 Yauzskaya Alleya, Moscow, 107564 Phone: +7 (499) 785-90-05
E. A. Shergina
Russian Federation
Elena A. Shergina - Candidate of Medical Sciences, Head of Functional Diagnostic Department of Center for Diagnosis and Rehabilitation of Respiratory Diseases
2 Yauzskaya Alleya, Moscow, 107564 Phone: +7 (499) 785-90-05
N. L. Karpina
Russian Federation
Nataliya L. Karpina - Doctor of Medical Sciences, Deputy Director for Research
2 Yauzskaya Alleya, Moscow, 107564 Phone: +7 (499) 785-90-05
References
1. Ardashev A.V., Oseroff O., Sansalone R., Zhelyakov E.G., Cappato R., Snezhitskiy V.A. et al. Recommendations for the management of COVID 19 patients regarding proarrhythmic effects of some current treatments, specifically if these patients suffer from arrhythmias, and for those receiving antiarrhythmic therapy. Eurasian Arrhythmology Association (EURA), Argentinean Society of Arrhythmias (SADEC), European Cardiac Arrhythmia Society (ECAS). Kardiologiia, 2020, vol. 60, no. 10, pp. 1-9. (In Russ.)
2. Belyaeva L.B. Patofiziologiya aritmiy: uchebnoye posobiye. [Pathophysiology of arrhythmias: a handbook]. Vitebsk, VGMU Publ., 2010.
3. Gorovenko I.I., Boltach A.V., Gayduk E.I., Novitskaya L.G., Silivanovich M.V., Gorovenko N.I. Basic mechanisms of metabolism in the myocardium and possible pathways of drug action. Lechebnoye Delo, 2018, vol. 61, no. 3, pp. 34-39. (In Russ.)
4. Ivanov G.G., Sula A.S. Dispersionnoye EKG-kartirovaniye: teoreticheskiye osnovy i klinicheskaya praktika. [Dispersion ECG mapping: theoretical foundations and clinical practice]. Moscow, Techosfera Publ., 2009.
5. Ilov N.N., Surikova O.N., Boytsov S.A., Zorin D.A., Nechepurenko A.A. Possibilities for predicting ventricular tachyarrhythmias in patients with heart failure with reduced ejection fraction based on surface electrocardiography. First results from a single-center prospective study. Rossiysky Kardiologicheskiy Journal, 2021, vol. 26, no. 12, pp. 46-61. (In Russ.) https://doi.org/10.15829/1560-4071-2021-4661
6. Iskenderov B.G. Elektricheskaya nestabilnost serdtsa pri arterialnoy gipertenzii: monografiya. [Electrical instability of the heart in arterial hypertension: monograph]. Penza, 2009.
7. Kushakovskiy M.S., Grishkin Yu.N. Aritmii serdtsa (Rasstroystva serdechnogo ritma narusheniya provodimosti. Prichiny, mekhanizmy, elektrokardiograficheskaya i elektrofiziologicheskaya diagnostika, klinika, lecheniye): rukovodstvo dlya vrachey. [Cardiac arrhythmias (Heart rhythm disorders, conduction disturbances. Causes, mechanisms, electrocardiographic and electrophysiological diagnostics, clinical signs and treatment): the guide for doctors]. 4th ed., suppl. and amend., St. Peterburg, OOO Izdatelstvo Foliant Publ., 2020.
8. Lysov A.V., Ivanova O.G., Mordyk A.V. Heart rate variability and general reactivity of the body during the main course of chemotherapy in patients with infiltrative pulmonary tuberculosis. Kazanskiy Med. Journal, 2007, vol. 88, no. 5, pp. 201-203. (In Russ.)
9. Makarov L.M. Physiological significance and normative parameters of frequency adaptation of the QT interval during Holter monitoring in healthy young individuals. Kardiologiia, 2008, no. 4, pp. 54-58. (In Russ.)
10. Mordyk A.V. Frequency and pathogenesis of adverse reactions to anti-tuberculosis drugs. Vestnik Sovremennoy Klinicheskoy Meditsiny, 2010, no. 1, pp. 16-21. (In Russ.)
11. Rybak O.K., Dovgalevsky P.Ya., Furman N.V., Shamyunov M.R., Averyanova A.P., Morozov I.A. Duration and dispersion of the QT interval in patients with angina pectoris and myocardial infarction. Rossiysky Kardiologicheskiy Journal, 2001, no. 2, pp. 5-9. (In Russ.)
12. Ryabykina G.V., Sobolev A.V. Kholterovskoye monitorirovaniye elektrokardiogrammy. V kn. Funktsionalnaya diagnostika: natsionalnoye rukovodstvo. [Holter monitoring of the electrocardiogram. In: Functional diagnostics: national guidelines]. Beresten N.F., Sandrikov V.A., Fedorova C.I., eds., Moscow, GEOTAR-Media Publ., 2019, pp. 99-117.
13. Batdorf N.J. Month-to-month and year-to-year reproducibility of high frequencies QRS ECG signals. Journal of Electrocardiology, 2004, vol. 37, no. 4, pp. 289-296.
14. Gussak I., Brugada P., Brugada J. et al. ECG phenomenon of idiopathic and paradoxical short QT intervals. Card. Electrophysiol. Rev., 2002, no. 6, pp. 49-53.
15. Haapalahti P., Makijarvi M., Montonen J. et al. Effects of cardiovascular autonomic function tests on Q-T dispersion in the12-lead electrocardiogram of healthy patients. J. Electrocardiology, 2000, no. 33, pp. 321-327.
16. Hennein R., Hwang S.J., Au R. et al. Barriers to medication adherence and links to cardiovascular disease risk factor control: The Framingham Heart Study. Intern. Med. J., 2018, vol. 48, no. 4, pp. 414-421.
17. Kalatsei L.V., Snezhitskiy V.A. Traditional and new electrocardiographic predictors of non-sustained polymorphic ventricular tachycardia caused by drug-induced long QT syndrome. Journal of Arrhythmology, 2022, vol. 29, no. 2, pp. 30-40. https://doi.org/10.35336/VA-2022-2-03.
18. Liu Y., Fu X., Gao H., Ren Y., Li H., He Y., Wang G. Effects of different concentrations of desflurane on index of cardiac electrophysiological balance in gynecologic surgery patients. Can. J. Physiol. Pharmacol., 2020, vol. 98, no. 5, pp. 332-335. https://doi.org/10.1139/cjpp-2019-0290
19. Murray A., McLaughlin N.B., Burke J.P. et al. Errors in manual measurement of QT intervals. Brit. Heart J., 1994, no. 71, pp. 386-390.
20. Rautaharju P.M., Zhang Z.M. Linearly scaled, rate-invariant normal limits for QT interval: eight decades of incorrect application of power functions. J. Cardiovasc. Electrophysiol., 2003, no. 13, pp. 1211-1218.
21. Tran H., White C.M., Chow M.S. An evaluation of the impact of gender and age on QT dispersion in healthy subjects. Ann. Noninvasive Electrocardiology, 2001, no. 6, pp. 129-133.
Review
For citations:
Nagaev A.I., Shergina E.A., Karpina N.L. Signs of Electrophysiological Myocardial Remodeling in Respiratory Tuberculosis Patients according to Daily ECG Monitoring Data. Tuberculosis and Lung Diseases. 2025;103(1):14-22. (In Russ.) https://doi.org/10.58838/2075-1230-2025-103-1-14-22